Jane Street’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Buy
331,701
+267,352
+415% +$8.58M ﹤0.01% 2742
2026
Q1
$2.1M Sell
64,349
-2,763
-4% -$90.6K ﹤0.01% 4990
2025
Q4
$2.13M Buy
+67,112
New +$2.02M ﹤0.01% 4694
2025
Q3
Sell
-34,743
Closed -$595K 11731
2025
Q2
$394K Buy
34,743
+7,765
+29% +$73.7K ﹤0.01% 7369
2025
Q1
$179K Buy
26,978
+15,001
+125% +$140K ﹤0.01% 8528
2024
Q4
$132K Sell
11,977
-318,465
-96% -$3.91M ﹤0.01% 8634
2024
Q3
$4.06M Buy
330,442
+255,028
+338% +$3.61M ﹤0.01% 3199
2024
Q2
$1.02M Buy
75,414
+61,040
+425% +$824K ﹤0.01% 5735
2024
Q1
$194K Sell
14,374
-36,412
-72% -$221K ﹤0.01% 8204
2023
Q4
$267K Buy
+50,786
New +$217K ﹤0.01% 7786
2023
Q2
Sell
-33,487
Closed -$279K 9535
2023
Q1
$279K Buy
33,487
+12,856
+62% +$116K ﹤0.01% 7314
2022
Q4
$190K Buy
20,631
+3,304
+19% +$34.4K ﹤0.01% 7701
2022
Q3
$222K Buy
+17,327
New +$276K ﹤0.01% 8014
2021
Q2
Sell
-10,718
Closed -$416K 10385
2021
Q1
$416K Buy
10,718
+6,053
+130% +$345K ﹤0.01% 7119
2020
Q4
$289K Sell
4,665
-1,588
-25% -$72.8K ﹤0.01% 6471
2020
Q3
$209K Sell
6,253
-4,049
-39% -$116K ﹤0.01% 6378
2020
Q2
$245K Buy
+10,302
New +$245K ﹤0.01% 6121

Other funds holding STOK

Jane Street's STOK Position: Q2 2026 in Review

Jane Street increased its Stoke Therapeutics (STOK) stake by 415% in Q2 2026, buying an estimated $8.58M and bringing the position to 331,701 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

Jane Street first reported a position in STOK in Q2 2020 and has held it in 17 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Jane Street held 331,701 shares of Stoke Therapeutics worth $10.9M as of Q2 2026.
  • Jane Street bought 267,352 Stoke Therapeutics shares in Q2 2026, an estimated $8.58M.
  • Stoke Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2742 holding.
  • Jane Street first reported a position in Stoke Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.